SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001178913-22-001980
Filing Date
2022-05-16
Accepted
2022-05-16 08:00:48
Documents
14
Period of Report
2022-05-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm   iXBRL 8-K 41046
2 EXHIBIT 10.1 exhibit_10-1.htm EX-10.1 175853
  Complete submission text file 0001178913-22-001980.txt   437296

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA entx-20220511.xsd EX-101.SCH 4734
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE entx-20220511_def.xml EX-101.DEF 18406
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE entx-20220511_lab.xml EX-101.LAB 28719
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE entx-20220511_pre.xml EX-101.PRE 20642
8 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 6885
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38556 | Film No.: 22925585
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences